Email
Password
Remember meForgot password?
    Log in with Twitter
| Press Release

Canbiola, Inc. CFO Discusses the CBD Market with Uptick Newswire’s Stock Day Podcast and Introduces an Orthopedist Who is Now a Believer in The Healing Benefits of CBD

PHOENIX, AZ / ACCESSWIRE / November 16, 2018 / Canbiola, Inc. (OTCQB: CANB) (The "Company") is a US Company specializing in the sale of a variety of Cannabidiol (CBD) based products. Stanley Teeple, CFO and Director, spoke with Stock Day's Everett Jolly.

"This company is in the most exciting industry since the advent of the dot-com days," said Teeple. "There is a lot of confusion about the marijuana plant, but to be clear, we sell CBD the extraction from the hemp plant. We are federally legal and all 50 states legal. Our labs developed products for purity and contain zero THC from the marijuana plant."

He went on to say they have developed and are selling a variety of CBD products from salves and gels to capsules and a CryoGel product. Teeple also said they just purchased a state-of-the-art facility, along with machinery that will allow them to keep up with current demand and growing demand in the future.

"Also, very exciting is that we obtained our QB status. This is huge in our industry, it opens us up to a whole new range of investment opportunities. We are really pleased to be jumping into the QB at a much higher level."

Teeple the introduced, Dr. David Weissberg who is now on the company's medical advisory board. With over 25 years in private practice, Dr. Weissberg specializes in a meticulous and moderate approach to orthopedic care. Jolly asked Dr. Weissberg to share his experience, as a medical professional, with CBD.

"I became a user of the product first, found an equally effective response, in terms of my pain and swelling," said Dr. Weissberg. "First I became a believer then I became a recommender. This has absolutely created a paradigm shift in my practice."

Dr. Weissberg said doctors across the country are trying to manage pain amid a national opioid crisis. He said they are really limited when treating patients and avoid addictive opioids.

"In the world of medicine today, we need a product that is safe, does not have drug reactions, does not have sedative type effects and low and behold, that is CBD," said Dr. Weissberg. "I am now giving CBD to hundreds of my patients and they are coming back with one amazing story after another."

Teeple added, "I love being part of a cutting-edge business where we change people's lives."

To hear the entire interview with Teeple and Dr. Weissberg, follow the link to the Stock Day podcast: https://upticknewswire.com/featured-interview-ceo-stanley-teeple-of-canbiola-inc-otcqb-canb/

About Canbiola, Inc.

Canbiola, Inc. is a public company trading under symbol CANB. Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states. The company has already launched several products found at www.canbiola.com.

The company also owns two technological solutions, WRAPmail (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at broker-dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance.

CONTACT INFORMATION:

Canbiola Investor Relations

Email: IR@canbiola.com

Phone: (516) 595-9544

Website: http://www.canbiola.com

Follow us on Twitter and Facebook

Forward Looking Statements

Forward-looking statements and risks and uncertainties Matters discussed in this press release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

About Uptick Newswire and the "Stock Day" Podcast

Founded in 2013, Uptick Newswire (https://upticknewswire.com/) is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both national and international media outlets. Uptick is the sole producer of its "Stock Day" Podcast, which is the number one radio show of its kind in America. The Uptick Network "Stock Day" Podcast is an extension of Uptick Newswire, which recently launched its Video Interview Studio located in Phoenix, Arizona.

Investors Hangout is a proud sponsor of "Stock Day," and Uptick Newswire encourages listeners to visit the company's message board at https://investorshangout.com/

SOURCE: Uptick Newswire



View source version on accesswire.com:
https://www.accesswire.com/528270/Canbiola-Inc-CFO-Discusses-the-CBD-Market-with-Uptick-Newswires-Stock-Day-Podcast-and-Introduces-an-Orthopedist-Who-is-Now-a-Believer-in-The-Healing-Benefits-of-CBD

Latest News
Top News